STIM Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
STIM is not a good buy right now. Despite bullish options positioning (very call-heavy) and a still-positive MACD, today’s -5% regular-session drop, heavy insider selling, and deteriorating margins/profitability in the latest quarter make the risk/reward unattractive for an impatient buyer at $2.09. I would stay on the sidelines (hold/avoid new buys) unless the stock can reclaim and hold above ~$2.27 (R1) with follow-through.
Price/Trend: STIM is trading $2.09 post-market after a -5.0% regular-session decline, sitting just above the pivot at 2.072—this is a fragile area where failed support often leads to the next support zone. Momentum: MACD histogram is positive (0.022) but ‘positively contracting,’ which typically signals bullish momentum is fading rather than accelerating. RSI(6) at ~55.7 is neutral, offering no oversold bounce signal. Moving averages: Converging MAs suggest consolidation/indecision rather than a clean uptrend. Levels: Pivot 2.072 (near-term decision point). Resistance: R1 2.266 then R2 2.387. Support: S1 1.877 then S2 1.756. A clean break below the pivot increases odds of a move toward 1.88. Pattern-based forward tilt (provided): Expected returns are muted (next week ~+1.25%, next month ~+0.18%), consistent with a low-conviction setup.
Intellectia Proprietary Trading Signals
Options sentiment is decisively bullish (call-heavy), which can fuel short-term bounces/squeezes if price reclaims resistance.
Revenue growth is extremely strong in the latest quarter (2025/Q3 revenue up ~101% YoY), showing demand/volume expansion.
MACD remains above zero, so the broader momentum backdrop hasn’t fully flipped bearish yet.
No supportive news flow in the last week to explain or counter the recent weakness.
Latest quarter: 2025/Q3. Revenue grew to $37.297M (+101.28% YoY), a strong top-line acceleration. However, profitability trended the wrong way: net income was -$9.045M (worse YoY), EPS -0.13 (worse YoY), and gross margin dropped to 45.87 (down ~39.29% YoY). Overall: high growth, but weakening unit economics and deeper losses—this reduces confidence that the current dip is a clean ‘buy-the-dip’ opportunity.
No analyst rating or price target change data was provided, so there’s no confirmed recent Wall Street upgrade/downgrade trend to lean on. In absence of that, the clearest ‘pros vs cons’ read from available data is: Pros—explosive revenue growth and bullish options positioning; Cons—heavy insider selling and margin/EPS deterioration. Congress trading: no recent data available. Influential/political trading: none reported in the provided dataset.
